Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Cardiol. 2004 Jul 1;94(1):115-8.

Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings.

Author information

1
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.

Abstract

The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.

PMID:
15219520
DOI:
10.1016/j.amjcard.2004.03.040
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center